PRECAUTIONS in package inserts include information such as Warning, Contraindications, Important Precautions, and Clinically Significant Adverse Reactions. When a new risk is identified, the PMDA thoroughly investigates the risks and discusses the necessity of revision of PRECAUTIONS with expert advisors so that the PMDA can recommend an additional safety measure to the MHLW. Following the investigation results by the PMDA, the MHLW issues a notice to revise PRECAUTIONS. The marketing authorization holders consequently revise PRECAUTIONS in accordance with the notice.
Back
Back
-
Regulations & Services of PMDA
Information about Approved Products in Japan
International Activities
Safety Information
Advanced Efforts
-
Information for approved products in Japan
Safety information
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnostics
Information for approved products in Japan
Regulatory science
-
Regulations and services of PMDA
Information for approved products in Japan
Procedures in Japan
Advanced efforts
Back
-
Regulations and Services of PMDA
Information for apporoved products in Japan
Safety information
Procedures in Japan
-
Regulations and Services of PMDA
Information for apporoved products in Japan
Safety information
Procedures in Japan
-
Reviews and Related Services
Regulatory Procedures
Post-marketing Safety Measures
-
Reviews and Related Services
Post-marketing Safety
Measures
Post-marketing Safety Measures